Arash Moradzadeh, MD, founder of AM Facial Plastics, shares his perspective on aesthetic treatments and trends poised to disrupt the market in 2026. He discusses the expanding role of GLP-1 RA medications in aesthetics, including what’s on the horizon for these therapies.
advertisement
Octane Aesthetics Tech Forum: Combination Treatment Strategies May Evolve for Patients Using GLP-1 RAs
Share
Save
Restart
Resume
Transcript
Octane Aesthetics Tech Forum: Combination Treatment Strategies May Evolve for Patients Using GLP-1 RAs
closeShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Arash Moradzadeh, MD, founder of AM Facial Plastics, shares his perspective on aesthetic treatments and trends poised to disrupt the market in 2026. He discusses the expanding role of GLP-1 RA medications in aesthetics, including what’s on the horizon for these therapies.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?